HighGravityData

UnitedHealth Group — Apr 17, 2025 release

Fiscal 2025 first-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000731766-25-000123
Open on SEC.gov ↗
Showing in the filing
Optum Health new value-based care patients
“650,000”
Period
FY2025
Measure
Company-defined measure
Source
Prose
All guidance in this release · 5
Adjusted earnings outlook for FY2025
“$26 to $26.50 Per Share”
Optum Health new value-based care patients for FY2025
“650,000”
Long-term earnings growth rate target for the long term
“13 to 16%”
Net earnings outlook for FY2025
“$24.65 to $25.15 Per Share”
Growth in people served by offerings for sen… for FY2025
“up to 800,000”
Exhibit 99.1 · the passage around this item
… earlier in the release
Share, Adjusted Earnings $7.20 Per Share • Revenues of $109.6 Billion Grew $9.8 Billion Year-Over-Year • Consumers Served by UnitedHealthcare Increased by 780,000 Year to Date • Optum Health Continues to Expect to Serve 650,000 New Value-Based Care Patients in 2025 (April 17, 2025) UnitedHealth Group (NYSE: UNH) reported first quarter 2025 results and revised its outlook for the year. “UnitedHealth Group grew to serve more people more comprehensively but did not perform up to our expectations, and we are aggressively addressing those challenges to position us well for the years ahead, and return to our long-term earnings growth rate target of 13 to 16%,” said Andrew Witty, chief executive officer of UnitedHealth Group. UnitedHealth Group revised its 2025 performance outlook established in December 2024 to net earnings of $24.65 to $25.15 per share and adjusted earnings of $26 to $26.50 per share. This outlook reflects two factors: • Heightened care activity indications within UnitedHealthcare’s Medicare Advantage businesses, which became visible as the quarter closed, far above the planned 2025 increase which was consistent with the elevated levels in 2024. This activity was most notable within physician and outpatient services. • Unanticipated changes in the profile of Optum Health members impacting planned 2025 reimbursement due to unexpectedly minimal 2024 beneficiary engagement by plans exiting marke
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.